Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Mallinckrodt
Colorcon
McKesson
AstraZeneca

Last Updated: June 28, 2022

DIDANOSINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

Drug patent expirations by year for DIDANOSINE
Recent Clinical Trials for DIDANOSINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
TTY BiopharmPhase 1
Chang Gung Memorial HospitalPhase 1
Asan Medical CenterPhase 4

See all DIDANOSINE clinical trials

Medical Subject Heading (MeSH) Categories for DIDANOSINE
Paragraph IV (Patent) Challenges for DIDANOSINE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
VIDEX Capsules didanosine 75 mg 020155 1 2011-06-06
VIDEX EC Delayed-release Capsules didanosine 200 mg, 250 mg and 400 mg 021183 1 2004-06-01

US Patents and Regulatory Information for DIDANOSINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma DIDANOSINE didanosine CAPSULE, DELAYED REL PELLETS;ORAL 090094-001 Sep 24, 2008 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Barr DIDANOSINE didanosine CAPSULE, DELAYED REL PELLETS;ORAL 077167-003 Dec 3, 2004 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Aurobindo Pharma DIDANOSINE didanosine CAPSULE, DELAYED REL PELLETS;ORAL 090094-004 Sep 24, 2008 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Aurobindo Pharma DIDANOSINE didanosine FOR SOLUTION;ORAL 078112-001 Mar 8, 2007 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Mylan Pharms Inc DIDANOSINE didanosine CAPSULE, DELAYED REL PELLETS;ORAL 090788-001 Apr 8, 2010 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Aurobindo DIDANOSINE didanosine TABLET, FOR SUSPENSION;ORAL 077275-002 Aug 14, 2012 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Aurobindo Pharma DIDANOSINE didanosine CAPSULE, DELAYED REL PELLETS;ORAL 090094-002 Sep 24, 2008 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Express Scripts
Merck
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.